Andrew Rowland
Flinders University
H-index: 34
Oceania-Australia
Top articles of Andrew Rowland
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches | Journal of extracellular vesicles | Joshua A Welsh Deborah CI Goberdhan Lorraine O'Driscoll Edit I Buzas Cherie Blenkiron | 2024/2 |
Special Paper: Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional … | The BMJ | Bradley D Menz Nicole M Kuderer Stephen Bacchi Natansh D Modi Benjamin Chin-Yee | 2024 |
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system | Jingying Tang Giang T Lam Robert D Brooks Mark Miles Zivile Useckaite | 2024/1/28 | |
Study of the ketohexokinase inhibitor PF‐06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy | Clinical and Translational Science | Ruolun Qiu Kari Fonseca Arthur Bergman Jian Lin David Tess | 2024/1 |
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials | BMC cancer | Lee X Li Mark A Socinski Ganessan Kichenadasse Christos S Karapetis Adel Shahnam | 2024/3/25 |
Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis | bmj | Bradley D Menz Nicole M Kuderer Stephen Bacchi Natansh D Modi Benjamin Chin-Yee | 2024/3/20 |
Accessibility of clinical study reports supporting medicine approvals: a cross-sectional evaluation | Journal of Clinical Epidemiology | Ashley M Hopkins Natansh D Modi Frank W Rockhold Tammy Hoffmann Bradley D Menz | 2024/3/1 |
A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies | BMC medicine | Natansh D Modi Ganessan Kichenadasse Tammy C Hoffmann Mark Haseloff Jessica M Logan | 2023/10/23 |
Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis. | Natansh Modi Ahmad Y Abuhelwa Andrew Rowland Bradley D Menz Ross Allan McKinnon | 2023/6/1 | |
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and … | John O Miners Thomas M Polasek Julie-Ann Hulin Andrew Rowland Robyn Meech | 2023/5/30 | |
A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution | Pharmaceutics | Radwan Ansaar Robyn Meech Andrew Rowland | 2023/4/12 |
Heterogeneity and utility of pharmaceutical company sharing of individual-participant data packages | JAMA oncology | Ashley M Hopkins Natansh D Modi Ahmad Y Abuhelwa Ganessan Kichenadasse Nicole M Kuderer | 2023/12/1 |
Analysis of extracellular vesicle and contaminant markers in blood derivatives using multiple reaction monitoring | Lauren A Newman Zivile Useckaite Ting Wu Michael J Sorich Andrew Rowland | 2023/2/12 | |
Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles | Proteomics | Zivile Useckaite Lauren A Newman Ashley M Hopkins Sonja Klebe Alex D Colella | 2023/11/30 |
Understanding the risk of drug interactions between ritonavir-containing COVID-19 therapies and small-molecule kinase inhibitors in patients with cancer | JCO Precision Oncology | Ashley M Hopkins Michael J Sorich Andrew J McLachlan Christos S Karapetis John O Miners | 2023/2 |
Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease | Biomedicines | Lauren A Newman Zivile Useckaite Jillian Johnson Michael J Sorich Ashley M Hopkins | 2022/1/17 |
Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases | Lauren A Newman Kate Muller Andrew Rowland | 2022/5 | |
The broader context of liquid biopsy in absorption, distribution, metabolism, and elimination | Clinical Pharmacology & Therapeutics | Andrew Rowland Zivile Useckaite Michael J Sorich | 2022/12 |
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials: Smoking and immunotherapy … | European Journal of Cancer | Ashley M Hopkins Ahmad Y Abuhelwa Ross A McKinnon Jessica M Logan Ganessan Kichenadasse | 2022/1/1 |
Enhanced bellmunt risk score for survival prediction in urothelial carcinoma treated with immunotherapy | Clinical Genitourinary Cancer | Ahmad Y Abuhelwa Joaquim Bellmunt Ganessan Kichenadasse Ross A McKinnon Andrew Rowland | 2022/4/1 |
Co-Authors
